EN
HI
Aspira Pathlab & Diagnostics Share price
ASPIRA
65
0.00 (0.00%)Last updated on 18 Sep, 2025 | 09:09 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
32.40
52 Week High
106.78
The current prices are delayed, login to your account for live prices
LoginAspira Pathlab & Diagnostics Share Key Metrics
Volume
0.00
Market Cap
66.90 CR
LTQ@LTP
0@65.00
ATP
0
Var Margin
26.85 %
Circuit Range
61.75-68.25
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
Aspira Pathlab & Diagnostics News
About Aspira Pathlab & Diagnostics
NSE : 0
BSE : 540788
ISIN : INE500C01017
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Dr. Haseeb Drabu | Chairman & Ind.Director |
| Dr. Pankaj J Shah | Managing Director & CEO |
Aspira Pathlab & Diagnostics Similar Stocks
Shree Pacetronix Ltd.
211.80
0.00 (0.00%)
JFL Life Sciences Ltd.
0.00
0.00 (0.00%)
Vista Pharmaceuticals Ltd.
9.65
-0.04 (0.41%)
Shelter Pharma Ltd.
44.15
0.00 (0.00%)
Concord Drugs Ltd.
68.55
0.00 (0.00%)
NG Industries Ltd.
161.80
4.70 (2.99%)
Vineet Laboratories Ltd.
35.50
0.00 (0.00%)
Centenial Surgical Suture Ltd.
109.30
0.00 (0.00%)
Amkay Products Ltd.
52.00
0.00 (0.00%)
Chandra Bhagat Pharma Ltd.
44.00
0.00 (0.00%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 27.89. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 0. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 54.49 & 3.63 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 66.90 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 106.78 & 32.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.